Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation

scientific article (publication date: 19 August 2008)

Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PMED.0050171
P3181OpenCitations bibliographic resource ID531278
P932PMC publication ID2517615
P698PubMed publication ID18715114
P5875ResearchGate publication ID23182335

P50authorMichal SchwartzQ21264411
Ninette AmariglioQ106204024
Anat LondonQ120600405
Ravid ShechterQ125288906
Asya RollsQ37834540
P2093author name stringJasmin Jacob-Hirsch
Yifat Segev
Gidon Rechavi
P2860cites workLPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microgliaQ24685951
Regeneration beyond the glial scarQ28239915
Reactive astrocytes protect tissue and preserve function after spinal cord injuryQ28248202
Microglia-mediated neurotoxicity: uncovering the molecular mechanismsQ29547835
Chondroitinase ABC promotes functional recovery after spinal cord injuryQ29615017
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsQ29616817
Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertionQ29618089
Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.Q33198766
Spinal cord repair: strategies to promote axon regenerationQ34132350
Repulsive factors and axon regeneration in the CNS.Q34141473
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomyQ34486849
Plasticity following lesion: help and harm from the immune system.Q34704770
The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosisQ34831062
Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injuryQ35090882
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosisQ35094527
Brain repair and neuroprotection by serum insulin-like growth factor I.Q35141396
Anti-inflammatory effects of heparin and its derivatives: inhibition of complement and of lymphocyte migrationQ35533559
Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarraysQ35548578
Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophagesQ35609982
Contribution of glial cells to the development of amyloid plaques in Alzheimer's diseaseQ35789671
How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytesQ35842732
Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury.Q50726567
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.Q51204340
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.Q52512624
Activation of microglial cells by beta-amyloid protein and interferon-gamma.Q53202007
Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats.Q55067631
T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNSQ57090609
Macrophages can modify the nonpermissive nature of the adult mammalian central nervous systemQ68543538
IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastaseQ77186261
Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microgliaQ79180789
New GABAergic interneurons supported by myelin-specific T cells are formed in intact adult spinal cordQ80412164
Chondroitin sulfate in palatal wound healingQ80908295
MicrogliaQ81034804
Microglia and neuroprotection: implications for Alzheimer's diseaseQ81683788
Proteoglycans and injury of the central nervous systemQ35964844
Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's diseaseQ36402221
Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injuryQ36402894
Molecular and cellular immune mediators of neuroprotectionQ36739426
Neuroprotective role of the innate immune system by microgliaQ36801872
Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injuryQ37138010
Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.Q37471962
The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitroQ40119262
Microglia provide neuroprotection after ischemiaQ40317498
A novel role for Sema3A in neuroprotection from injury mediated by activated microglia.Q40318758
Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.Q40470094
Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia.Q40482519
Chondroitin sulfate proteoglycan with neurite-inhibiting activity is up-regulated following peripheral nerve injuryQ42450980
Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injuryQ42606175
Autoreactive T cells promote post-traumatic healing in the central nervous system.Q42691926
White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosisQ43838103
Macrophage-derived factors stimulate optic nerve regeneration.Q44376583
Concentration-dependent actions of glial chondroitin sulfate on the neuritic growth of midbrain neuronsQ44414248
A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and miceQ45079445
NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.Q46345563
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditionsQ46891042
Growth-modulating molecules are associated with invading Schwann cells and not astrocytes in human traumatic spinal cord injury.Q48267170
Triggering the brain's pathology sensor.Q48357297
Differential effects of Th1 and Th2 lymphocyte supernatants on human microgliaQ48384113
The cellular inflammatory response in human spinal cords after injuryQ48384322
IGF-I and microglia/macrophage proliferation in the ischemic mouse brainQ48552439
Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory moleculesQ48558550
Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methodsQ48623708
Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine/paracrine actions of IGF-I within wounds of the rat brainQ48677755
Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells.Q48691176
'Semifree-floating' treatment: a simple and fast method to process consecutive sections for immunohistochemistry and neuronal tracingQ48774819
Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cordQ48819305
Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter.Q48824436
Regenerative failure: a potential mechanism for neuritic dystrophy in Alzheimer's diseaseQ48880786
Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell culturesQ48973809
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectmacrophageQ184204
microgliaQ1622829
P304page(s)e171
P577publication date2008-08-19
P1433published inPLOS MEDICINEQ1686921
P1476titleTwo faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation
P478volume5

Reverse relations

cites work (P2860)
Q38793073"Targeting astrocytes in CNS injury and disease: A translational research approach".
Q401049882-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.
Q923705482-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions
Q37261081A pilot study of poly(N-isopropylacrylamide)-g-polyethylene glycol and poly(N-isopropylacrylamide)-g-methylcellulose branched copolymers as injectable scaffolds for local delivery of neurotrophins and cellular transplants into the injured spinal cor
Q28392297ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease
Q31122599Ablation of keratan sulfate accelerates early phase pathogenesis of ALS.
Q33969817Abrogation of β-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury.
Q28744661Activated microglia inhibit axonal growth through RGMa
Q37128209Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents
Q39821138Alterations of protein composition along the rostro-caudal axis after spinal cord injury: proteomic, in vitro and in vivo analyses
Q36092501An overview of pharmacological approaches for management and repair of spinal cord injuries
Q38966132Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases
Q36554467Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells
Q37693739Bridging the Divide between Neuroprosthetic Design, Tissue Engineering and Neurobiology
Q45376613CNS repair requires both effector and regulatory T cells with distinct temporal and spatial profiles
Q82901089Chondroitin beta-1,4-N-acetylgalactosaminyltransferase-1 missense mutations are associated with neuropathies
Q39266450Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.
Q37196329Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment.
Q34282030Chondroitinase and growth factors enhance activation and oligodendrocyte differentiation of endogenous neural precursor cells after spinal cord injury
Q46177334Comment on "chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination".
Q36090107Demyelination as a rational therapeutic target for ischemic or traumatic brain injury
Q93140446Detecting the long non‑coding RNA signature related to spinal cord ependymal tumor subtype using a genome‑wide methylome analysis approach
Q33488236Differential expression of receptor protein tyrosine phosphatases accompanies the reorganisation of the retina upon laser lesion
Q49397380Environmental cues determine the fate of astrocytes after spinal cord injury
Q47388453Epothilone B impairs functional recovery after spinal cord injury by increasing secretion of macrophage colony-stimulating factor
Q34414830Examination of the combined effects of chondroitinase ABC, growth factors and locomotor training following compressive spinal cord injury on neuroanatomical plasticity and kinematics
Q33906928Extracellular matrix regulation of inflammation in the healthy and injured spinal cord
Q48385724Extrinsic and intrinsic factors controlling axonal regeneration after spinal cord injury
Q93083711Facile saccharide-free mimetics that recapitulate key features of glycosaminoglycan sulfation patterns
Q38366783From demyelination to remyelination: the road toward therapies for spinal cord injury
Q27024453Function of microglia and macrophages in secondary damage after spinal cord injury
Q36765022Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology
Q38206485Glial scar and immune cell involvement in tissue remodeling and repair following acute CNS injuries
Q39181869Glial scar-modulation as therapeutic tool in spinal cord injury in animal models.
Q38046114Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'.
Q27308097Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury
Q26995364How do immune cells support and shape the brain in health, disease, and aging?
Q92330636Identification and characterization of microglia/macrophages in the granuloma microenvironment of encephalic schistosomiasis japonicum
Q55253477Identification of a critical sulfation in chondroitin that inhibits axonal regeneration.
Q46387484Immunobiology of spinal cord injuries and potential therapeutic approaches
Q37310621Immunomodulatory and anti-inflammatory effects of chondroitin sulphate
Q38226802In the presence of danger: The extracellular matrix defensive response to central nervous system injury.
Q27307172Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice
Q57599442Innate Immunity in the CNS - A Focus on the Myeloid Cell
Q48258249Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury
Q52145462Lack of NG2 exacerbates neurological outcome and modulates glial responses after traumatic brain injury.
Q64054986Macrophage centripetal migration drives spontaneous healing process after spinal cord injury
Q38193884Macrophages and CNS remyelination
Q53180449Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.
Q39833593Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair
Q89810267Microglia control vascular architecture via a TGFβ1 dependent paracrine mechanism linked to tissue mechanics
Q35394922Microglial and macrophage polarization—new prospects for brain repair
Q37983759Microglial carbohydrate-binding receptors for neural repair.
Q39852498Monocyte-Derived Macrophages Contribute to Spontaneous Long-Term Functional Recovery after Stroke in Mice.
Q39388337Myeloid Cells in the Central Nervous System
Q50626932Myeloid-Specific Blockade of Notch Signaling by RBP-J Knockout Attenuates Spinal Cord Injury Accompanied by Compromised Inflammation Response in Mice.
Q55082031Neural crest stem cells protect spinal cord neurons from excitotoxic damage and inhibit glial activation by secretion of brain-derived neurotrophic factor.
Q26995185Neural stem cell niches in health and diseases
Q94311674Neuronal injury and repair: for glial scar protein, timing is everything
Q34501419Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages.
Q48311249Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand
Q48098141Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix.
Q30238775Overview of Traumatic Brain Injury: An Immunological Context
Q38132334Pathophysiology of the brain extracellular matrix: a new target for remyelination.
Q90248349Pericytes Act as Key Players in Spinal Cord Injury
Q53412902Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia.
Q52646465Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury.
Q35729506Phenotypic assays to identify agents that induce reactive gliosis: a counter-screen to prioritize compounds for preclinical animal studies
Q38017625Reactive astrogliosis after spinal cord injury-beneficial and detrimental effects.
Q28389274Reciprocal modulation between microglia and astrocyte in reactive gliosis following the CNS injury
Q33839440Regional heterogeneity in astrocyte responses following contusive spinal cord injury in mice
Q53254561Regulation of chondroitin sulphate proteoglycan and reactive gliosis after spinal cord transection: effects of peripheral nerve graft and fibroblast growth factor 1.
Q37492253Regulation of innate immune responses in the brain
Q30424827Regulatory T cells in CNS injury: the simple, the complex and the confused
Q57031212Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma
Q34168279Role of microglia in neurotrauma
Q48148010Sex differences in glia reactivity after cortical brain injury.
Q88538756Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses
Q37833644Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages
Q28394140Stem cell therapy for central nerve system injuries: glial cells hold the key
Q39236820Sulfated glycosaminoglycans in protein aggregation diseases
Q28741573Syndromics: a bioinformatics approach for neurotrauma research
Q34798895Targeted downregulation of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase significantly mitigates chondroitin sulfate proteoglycan-mediated inhibition
Q92565165Targeting the Chondroitin Sulfate Proteoglycans: Evaluating Fluorinated Glucosamines and Xylosides in Screens Pertinent to Multiple Sclerosis
Q85258862Temporal and spatial expression of KIF3B after acute spinal cord injury in adult rats
Q37346515The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance
Q36686413The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice
Q52669755The Biology of Regeneration Failure and Success After Spinal Cord Injury.
Q38691715The Role of Decidual Macrophages During Normal and Pathological Pregnancy
Q42562079The association between laminin and microglial morphology in vitro.
Q37396812The bright side of the glial scar in CNS repair
Q88230827The extracellular matrix: Focus on oligodendrocyte biology and targeting CSPGs for remyelination therapies
Q38122112The glial scar in spinal cord injury and repair
Q27311808The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair
Q92721012The origin, fate, and contribution of macrophages to spinal cord injury pathology
Q36520580The reactions and role of NG2 glia in spinal cord injury
Q38758872The regenerative effects of electromagnetic field on spinal cord injury
Q43873599The regulatory peptide pidotimod facilitates M2 macrophage polarization and its function
Q38061012The retina as a window to the brain-from eye research to CNS disorders
Q36954609The retinal pigment epithelium as a gateway for monocyte trafficking into the eye.
Q37295387Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis
Q54035553Towards personalized cell-replacement therapies for brain repair.
Q48852948Transplantation of Schwann cells differentiated from adipose-derived stem cells modifies reactive gliosis after contusion brain injury in rats
Q64061191Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms
Q33748201Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis
Q39788151γ-Secretase component presenilin is important for microglia β-amyloid clearance.

Search more.